device contains a library of insulin products, unique identifiers that allow the pen administration device to identify the correct product (e.g., insulin pen), size, and concentration when the insulin pen is scanned and loaded into the pen administration device or administered to the patient. Add...
Patient vs. Physician Control of Insulin Dose Adjustment and Administration: An Exploratory Study M.P. Golden, / D.L. Gray, / D.G. Marrero, Citation Information: Journal of Pediatric Endocrinology and Metabolism. Volume 1, Issue 2-3, Pages 145–150, ISSN (Online) 2191-0251, ISSN (Prin...
Data from the medication administration record (MAR) were collected on each patient for 5 days. Study outcomes included the percentage of glucose readings defined as hypoglycemia (≤ 60 mg/dL) and hyperglycemia (≥ 180 mg/dL). All process and outcome measures were analyzed using descriptive ...
This is often inconvenient for the patient. This type of regimen is also associated with weight gain. In many people with type 1 diabetes, the blood glucose level rises in the early morning (around 3 to 4 am) due to an increased secretion of growth hormone at this time. This is known ...
(yes/no); problems related to injection administration (discomfort/ pain/itching at injection site) (yes/no); change in dosage (yes/no); skipped dose(s) for at least once a week (yes/no); the number of skipped doses and most commonly skipped dose (morning/noon/evening/night) within ...
Administration advice:For subcutaneous administration; do not administer IV or via insulin pump This insulin is a suspension and must be visually inspected and resuspended immediately before use; see preparation techniques below. Administer subcutaneously into the abdomen, buttocks, thigh, or upper arm ...
at least for the ex- tended-acting insulin preparations, by the observa- tion that the coefficient of variation of pre-breakfast blood glucose levels within individuals is similar to that at other times of day (when patient behaviour would be expected to have a much greater effect) [33]. ...
[54]. The lower incidence of major and nocturnal hypoglycemia and flexibility of administration with premix insulin analogues have made this regimen a better choice over human premix insulins when initiating insulin therapy. However, insulin degludec/insulin aspart 70/30 may be preferred over other ...
We reasoned that the insulin-sensitizing effect of DMR might be strengthened by coadministration of a glucagon-like peptide-1 receptor agonist (GLP-1RA), anantidiabetic drugthat stimulates endogenous insulin production and protects the remaining pancreatic beta cells. Patients who replaced their insulin...
Here, two first-in-human phase 1 studies were conducted in parallel to explore two dosing schedules (administration once weekly and every 3 weeks) to determine the maximum-tolerated dose (MTD) and/or relevant biological dose (RBD) of intravenous (IV) xentuzumab in patients with advanced solid...